Effect of roxadustat on intact and C-terminal FGF23 levels in patients undergoing peritoneal dialysis: a <i>post hoc</i> analysis of a randomized trial.

Clin Kidney J · 2023 · PMC10539215 · PMID 37779854

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significanceP = .050actually significant

Hepcidin levels were decreased after 12 weeks of roxadustat administration, with borderline significance in the entire cohort {140.2 ng/ml [interquartile range (IQR) 85.2–194.4] versus 110.5 ng/ml [IQR 46.1–167.1], P = .050} (Table 1 ).

also in 1,449 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.